Amphotericin B (AmB) represents a clinically vital but toxic antibiotic that additionally has the ability to form ion channels in biological membranes, a capacity normally associated with proteins. Better understanding the dynamics of channel formation and how it relates to AmB’s antifungal activity would stand to enable both the rational development of derivatives that have a better therapeutic index, and the design of the small molecule prosthetics with the capacity to treat currently incurable human diseases. Efficient access to derivatives of AmB would greatly facilitate these goals. In this context, several methodological advances have been made that were stimulated by studies toward an efficient and flexible total synthesis of AmB. ...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Invasive fungal infections remain a leading cause of morbidity and mortality in the world, accountin...
Amphotericin B (AmB) represents a clinically vital but toxic antibiotic that additionally has the ab...
Despite almost 40 years of investigation, the mechanism of action of amphotericin B (AmB), a potent ...
The polyene macrolide amphotericin B (AmB) remains a critically vital antifungal as the last line of...
Despite almost 40 years of investigation, the mechanism of action of amphotericin B (AmB), a potent ...
Amphotericin B (AmB) is a clinically vital, yet highly toxic antifungal agent that is dependent on t...
Mycosamine-containing polyene macrolides represent a large family of natural products with antifunga...
The small molecule Amphotericin B (AmB) is a natural product that is utilized in the treatment of sy...
In contrast to peptides, oligonucleotides, and increasingly oligosacharides, which can be rapidly an...
The polyene macrolide amphotericin B (AmB) remains a critically vital antifungal as the last line of...
Many small molecules targeted for synthesis in the laboratory are inherently modular in their constr...
A one-pot glycosylation method was developed to simplify the synthesis of precursors of 3-O-methyl-m...
Since its discovery in 1955, amphotericin B (AmB) has been a vital clinical agent. It remains the dr...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Invasive fungal infections remain a leading cause of morbidity and mortality in the world, accountin...
Amphotericin B (AmB) represents a clinically vital but toxic antibiotic that additionally has the ab...
Despite almost 40 years of investigation, the mechanism of action of amphotericin B (AmB), a potent ...
The polyene macrolide amphotericin B (AmB) remains a critically vital antifungal as the last line of...
Despite almost 40 years of investigation, the mechanism of action of amphotericin B (AmB), a potent ...
Amphotericin B (AmB) is a clinically vital, yet highly toxic antifungal agent that is dependent on t...
Mycosamine-containing polyene macrolides represent a large family of natural products with antifunga...
The small molecule Amphotericin B (AmB) is a natural product that is utilized in the treatment of sy...
In contrast to peptides, oligonucleotides, and increasingly oligosacharides, which can be rapidly an...
The polyene macrolide amphotericin B (AmB) remains a critically vital antifungal as the last line of...
Many small molecules targeted for synthesis in the laboratory are inherently modular in their constr...
A one-pot glycosylation method was developed to simplify the synthesis of precursors of 3-O-methyl-m...
Since its discovery in 1955, amphotericin B (AmB) has been a vital clinical agent. It remains the dr...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Amphotericin B (AmB) is a polyene macrolide natural product with two major functions: antifungal act...
Invasive fungal infections remain a leading cause of morbidity and mortality in the world, accountin...